Literature DB >> 15345320

Insulin and glucose induced changes in expression level of nucleoside transporters and adenosine transport in rat T lymphocytes.

Monika Sakowicz1, Andrzej Szutowicz, Tadeusz Pawelczyk.   

Abstract

Adenosine is an endogenous agent exerting potent action on the immune system including regulation of lymphocyte functioning. Impaired T lymphocyte functioning is a common feature of diabetes. The aims of this study were to examine the effects of glucose and insulin on nucleoside transporters (NT) expression level and adenosine (Ado) transport in rat T lymphocytes cultured under the defined concentrations of glucose and insulin. Performed experiments revealed that rat T lymphocytes expressed the equilibrative nucleoside transporter type 1 and 2 (rENT1, rENT2) and concentrative nucleoside transporter type 2 (rCNT2). The mRNA levels of rENT2 and rCNT2 were highly dependent on insulin but were not affected by changes in extracellular glucose concentration. Exposition of T cells to 10nM insulin resulted in 73% increase in rENT2 mRNA and 50% decrease in the rCNT2 mRNA level. The level of rENT1 mRNA was sensitive to extracellular glucose concentration but not to insulin. The highest differences among cells cultured in high (20mM) and low (5mM) glucose were observed in equilibrative nitrobenzylthioinosine sensitive adenosine transport, which was lowered by 65% in cells cultured at high glucose. Alterations in adenosine transport were accompanied by changes in adenosine accumulation in the cell. These results indicate that adenosine transport in rat T lymphocytes is independently and differentially regulated by glucose and insulin by means of changes in the nucleoside transporters expression level. Altered adenosine transport has a great impact on its intracellular level. This suggests that under diabetic conditions adenosine action on T lymphocytes might be altered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345320     DOI: 10.1016/j.bcp.2004.06.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

Review 1.  Regulation of lymphocyte function by adenosine.

Authors:  Joel Linden; Caglar Cekic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

2.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

3.  Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes.

Authors:  Monika Sakowicz-Burkiewicz; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

4.  Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.

Authors:  Bagher Larijani; Ramin Heshmat; Mina Ebrahimi-Rad; Shohreh Khatami; Shirin Valadbeigi; Reza Saghiri
Journal:  Enzyme Res       Date:  2016-12-05

5.  Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.

Authors:  Sebastián Alarcón; Wallys Garrido; Génesis Vega; Claudio Cappelli; Raibel Suárez; Carlos Oyarzún; Claudia Quezada; Rody San Martín
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.

Authors:  Catalina Kretschmar; Carlos Oyarzún; Cristopher Villablanca; Catherinne Jaramillo; Sebastián Alarcón; Gustavo Perez; Montserrat M Díaz-Encarnación; Marçal Pastor-Anglada; Wallys Garrido; Claudia Quezada; Rody San Martín
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.